Company Filing History:
1 out of 61 
1 out of 2,622 
Years Active: 2025
Title: Valerie Gouon-Evans: Innovator in Nucleoside Modified mRNA
Introduction
Valerie Gouon-Evans is a prominent inventor based in Newton, MA, known for her groundbreaking work in the field of nucleoside modified mRNA. Her innovative research focuses on developing compositions and methods that have significant implications for treating liver diseases.
Latest Patents
Valerie holds a patent for "Nucleoside modified mRNA and uses thereof." This patent discloses compositions and methods for utilizing nucleoside modified mRNA that encodes for at least one liver regenerative factor. The invention also relates to compositions and methods for using nucleoside modified mRNA complexed to nanoparticles. These compositions and methods are particularly useful for treating acute liver diseases, chronic liver diseases, and acetaminophen overdose.
Career Highlights
Throughout her career, Valerie has made significant contributions to the medical field. She has worked with esteemed organizations such as Boston Medical Center Corporation and the University of Pennsylvania. Her work has been instrumental in advancing the understanding and treatment of liver-related health issues.
Collaborations
Valerie has collaborated with notable professionals in her field, including Drew Weissman and Norbert Pardi. These collaborations have further enhanced her research and its applications in medical science.
Conclusion
Valerie Gouon-Evans is a trailblazer in the realm of nucleoside modified mRNA, with her innovative patent paving the way for new treatments for liver diseases. Her contributions to the field highlight the importance of research and collaboration in advancing medical science.